The Tennessee-based health system will continue to sell hospitals as it looks to focus more on capital-efficient outpatient ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

The goodwill impairment charge is meant to realign Centene’s value on its own books with it value in the market, which has ...

The healthcare giant beat Wall Street expectations in the third quarter, but reported a net loss after recording a $5.7 ...

The company has started to score insurers on their success in making rate data available online. Large payers tend to do ...

Fewer than 30% of health system leaders said they earned significant return on investment from virtual care offerings, ...

Optum Real allows providers to receive information about patients’ health benefits in real time, the company said.

The operator increased its outlook after posting earnings growth in the third quarter, aided by strong demand for services in ...

The massive PBM’s announcement comes as the drug middlemen attempt to lessen regulatory scrutiny. The company also said it ...